Compounds > haloperidol

haloperidol and indalpine

haloperidol has been researched along with indalpine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hesselink, MB; Kruse, CG; McCreary, AC; Smid, P; Stroomer, CN; Tipker, K; Tulp, MT; van der Heyden, JA; van Hes, R1
Coolen, HK; de Moes, JP; den Hartog, AP; Herremans, AH; Hesselink, MB; Keizer, HG; Kruse, CG; McCreary, AC; Niemann, LC; Plekkenpol, RH; Smid, P; Stork, B; Stroomer, CN; Tulp, MT; van Hes, R; van Stuivenberg, HH1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P1

Other Studies

4 other study(ies) available for haloperidol and indalpine

ArticleYear
SLV310, a novel, potential antipsychotic, combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition.
    Bioorganic & medicinal chemistry letters, 2003, Feb-10, Volume: 13, Issue:3

    Topics: 5-Hydroxytryptophan; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; CHO Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Indicators and Reagents; Mice; Motor Activity; Phthalimides; Pyridines; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship

2003
Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibition.
    Journal of medicinal chemistry, 2005, Nov-03, Volume: 48, Issue:22

    Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoxazines; Biological Transport; Cell Line; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; Indoles; Male; Models, Molecular; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship

2005
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 240, Issue:1

    Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior

1987